img

Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

The market is primarily driven by the growing demand for veterinary drugs owing to the rising prevalence of zoonotic diseases, the increasing number of veterinary pharmaceutical players, and the growing animal population, pet ownership, pet humanization & pet expenditure.
Veterinary Active Pharmaceutical Ingredients Manufacturing report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Veterinary Active Pharmaceutical Ingredients Manufacturing market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Companion Animals and Production/Food Animals are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Veterinary Active Pharmaceutical Ingredients Manufacturing industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Veterinary Active Pharmaceutical Ingredients Manufacturing key manufacturers include Alivira Animal Health Ltd., Excel Industries Ltd., Ofichem Group, Chempro Pharma Private Ltd., Menadiona, SUANFARMA, Vetpharma (Insud Pharma, S.L.U), Siflon Drugs and Qilu Pharma, etc. Alivira Animal Health Ltd., Excel Industries Ltd., Ofichem Group are top 3 players and held % sales share in total in 2022.
Veterinary Active Pharmaceutical Ingredients Manufacturing can be divided into Antiparasitic, Anti-infectives, NSAIDs and Others, etc. Antiparasitic is the mainstream product in the market, accounting for % sales share globally in 2022.
Veterinary Active Pharmaceutical Ingredients Manufacturing is widely used in various fields, such as Companion Animals and Production/Food Animals, etc. Companion Animals provides greatest supports to the Veterinary Active Pharmaceutical Ingredients Manufacturing industry development. In 2022, global % sales of Veterinary Active Pharmaceutical Ingredients Manufacturing went into Companion Animals filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Veterinary Active Pharmaceutical Ingredients Manufacturing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Alivira Animal Health Ltd.
Excel Industries Ltd.
Ofichem Group
Chempro Pharma Private Ltd.
Menadiona
SUANFARMA
Vetpharma (Insud Pharma, S.L.U)
Siflon Drugs
Qilu Pharma
FIS - Fabbrica Italiana Sintetici S.p.A.
Segment by Type
Antiparasitic
Anti-infectives
NSAIDs
Others

Segment by Application


Companion Animals
Production/Food Animals

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Veterinary Active Pharmaceutical Ingredients Manufacturing market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Veterinary Active Pharmaceutical Ingredients Manufacturing, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Veterinary Active Pharmaceutical Ingredients Manufacturing industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Veterinary Active Pharmaceutical Ingredients Manufacturing in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Veterinary Active Pharmaceutical Ingredients Manufacturing introduction, etc. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Veterinary Active Pharmaceutical Ingredients Manufacturing market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
1.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Product Overview
1.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Segment by Type
1.2.1 Antiparasitic
1.2.2 Anti-infectives
1.2.3 NSAIDs
1.2.4 Others
1.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Type
1.3.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Overview by Type (2024-2034)
1.3.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Historic Market Size Review by Type (2024-2024)
1.3.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Breakdown by Type (2024-2024)
1.4.2 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Breakdown by Type (2024-2024)
2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Competition by Company
2.1 Global Top Players by Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (2024-2024)
2.2 Global Top Players by Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue (2024-2024)
2.3 Global Top Players by Veterinary Active Pharmaceutical Ingredients Manufacturing Price (2024-2024)
2.4 Global Top Manufacturers Veterinary Active Pharmaceutical Ingredients Manufacturing Manufacturing Base Distribution, Sales Area, Product Type
2.5 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Competitive Situation and Trends
2.5.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Veterinary Active Pharmaceutical Ingredients Manufacturing Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing as of 2022)
2.7 Date of Key Manufacturers Enter into Veterinary Active Pharmaceutical Ingredients Manufacturing Market
2.8 Key Manufacturers Veterinary Active Pharmaceutical Ingredients Manufacturing Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Veterinary Active Pharmaceutical Ingredients Manufacturing Status and Outlook by Region
3.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Historic Market Size by Region
3.2.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Volume by Region (2024-2024)
3.2.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Value by Region (2024-2024)
3.2.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Forecasted Market Size by Region
3.3.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Volume by Region (2024-2034)
3.3.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Value by Region (2024-2034)
3.3.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Veterinary Active Pharmaceutical Ingredients Manufacturing by Application
4.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Segment by Application
4.1.1 Companion Animals
4.1.2 Production/Food Animals
4.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size by Application
4.2.1 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Overview by Application (2024-2034)
4.2.2 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Historic Market Size Review by Application (2024-2024)
4.2.3 Global Veterinary Active Pharmaceutical Ingredients Manufacturing Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Breakdown by Application (2024-2024)
4.3.2 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Breakdown by Application (2024-2024)
5 North America Veterinary Active Pharmaceutical Ingredients Manufacturing by Country
5.1 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Historic Market Size by Country
5.1.1 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Volume by Country (2024-2024)
5.1.3 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Value by Country (2024-2024)
5.2 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Forecasted Market Size by Country
5.2.1 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Volume by Country (2024-2034)
5.2.2 North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Value by Country (2024-2034)
6 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing by Country
6.1 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Historic Market Size by Country
6.1.1 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Volume by Country (2024-2024)
6.1.3 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Value by Country (2024-2024)
6.2 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Forecasted Market Size by Country
6.2.1 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Volume by Country (2024-2034)
6.2.2 Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Value by Country (2024-2034)
7 Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing by Region
7.1 Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Historic Market Size by Region
7.1.1 Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Forecasted Market Size by Region
7.2.1 Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Value by Region (2024-2034)
8 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing by Country
8.1 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Historic Market Size by Country
8.1.1 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Volume by Country (2024-2024)
8.1.3 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Value by Country (2024-2024)
8.2 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Forecasted Market Size by Country
8.2.1 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Volume by Country (2024-2034)
8.2.2 Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Value by Country (2024-2034)
9 Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing by Country
9.1 Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Historic Market Size by Country
9.1.1 Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Forecasted Market Size by Country
9.2.1 Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Alivira Animal Health Ltd.
10.1.1 Alivira Animal Health Ltd. Company Information
10.1.2 Alivira Animal Health Ltd. Introduction and Business Overview
10.1.3 Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Products Offered
10.1.5 Alivira Animal Health Ltd. Recent Development
10.2 Excel Industries Ltd.
10.2.1 Excel Industries Ltd. Company Information
10.2.2 Excel Industries Ltd. Introduction and Business Overview
10.2.3 Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Products Offered
10.2.5 Excel Industries Ltd. Recent Development
10.3 Ofichem Group
10.3.1 Ofichem Group Company Information
10.3.2 Ofichem Group Introduction and Business Overview
10.3.3 Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Products Offered
10.3.5 Ofichem Group Recent Development
10.4 Chempro Pharma Private Ltd.
10.4.1 Chempro Pharma Private Ltd. Company Information
10.4.2 Chempro Pharma Private Ltd. Introduction and Business Overview
10.4.3 Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Products Offered
10.4.5 Chempro Pharma Private Ltd. Recent Development
10.5 Menadiona
10.5.1 Menadiona Company Information
10.5.2 Menadiona Introduction and Business Overview
10.5.3 Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Products Offered
10.5.5 Menadiona Recent Development
10.6 SUANFARMA
10.6.1 SUANFARMA Company Information
10.6.2 SUANFARMA Introduction and Business Overview
10.6.3 SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2024-2024)
10.6.4 SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Products Offered
10.6.5 SUANFARMA Recent Development
10.7 Vetpharma (Insud Pharma, S.L.U)
10.7.1 Vetpharma (Insud Pharma, S.L.U) Company Information
10.7.2 Vetpharma (Insud Pharma, S.L.U) Introduction and Business Overview
10.7.3 Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Products Offered
10.7.5 Vetpharma (Insud Pharma, S.L.U) Recent Development
10.8 Siflon Drugs
10.8.1 Siflon Drugs Company Information
10.8.2 Siflon Drugs Introduction and Business Overview
10.8.3 Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Products Offered
10.8.5 Siflon Drugs Recent Development
10.9 Qilu Pharma
10.9.1 Qilu Pharma Company Information
10.9.2 Qilu Pharma Introduction and Business Overview
10.9.3 Qilu Pharma Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Qilu Pharma Veterinary Active Pharmaceutical Ingredients Manufacturing Products Offered
10.9.5 Qilu Pharma Recent Development
10.10 FIS - Fabbrica Italiana Sintetici S.p.A.
10.10.1 FIS - Fabbrica Italiana Sintetici S.p.A. Company Information
10.10.2 FIS - Fabbrica Italiana Sintetici S.p.A. Introduction and Business Overview
10.10.3 FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales, Revenue and Gross Margin (2024-2024)
10.10.4 FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Products Offered
10.10.5 FIS - Fabbrica Italiana Sintetici S.p.A. Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Industrial Chain Analysis
11.4 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Dynamics
11.4.1 Veterinary Active Pharmaceutical Ingredients Manufacturing Industry Trends
11.4.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Drivers
11.4.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Challenges
11.4.4 Veterinary Active Pharmaceutical Ingredients Manufacturing Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Veterinary Active Pharmaceutical Ingredients Manufacturing Distributors
12.3 Veterinary Active Pharmaceutical Ingredients Manufacturing Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Antiparasitic
Table 2. Major Company of Anti-infectives
Table 3. Major Company of NSAIDs
Table 4. Major Company of Others
Table 5. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Type (2024-2024) & (Tons)
Table 7. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Type (2024-2024)
Table 8. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Type (2024-2024) & (US& Million)
Table 9. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share in Value by Type (2024-2024)
Table 10. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Price by Type (2024-2024) & (US$/Ton)
Table 11. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Type (2024-2034) & (Tons)
Table 12. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Type (2024-2034)
Table 15. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Price by Type (2024-2034) & (US$/Ton)
Table 16. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Type (2024-2024) & (Tons)
Table 17. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons) by Type (2024-2024)
Table 19. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons) by Type (2024-2024)
Table 21. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons) by Type (2024-2024)
Table 23. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons) by Type (2024-2024)
Table 25. Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Type (2024-2024) & (US$ Million)
Table 26. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Company (2024-2024) & (Tons)
Table 27. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Share by Company (2024-2024)
Table 28. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue Share by Company (2024-2024)
Table 30. Global Market Veterinary Active Pharmaceutical Ingredients Manufacturing Price by Company (2024-2024) & (US$/Ton)
Table 31. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Active Pharmaceutical Ingredients Manufacturing as of 2022)
Table 34. Date of Key Manufacturers Enter into Veterinary Active Pharmaceutical Ingredients Manufacturing Market
Table 35. Key Manufacturers Veterinary Active Pharmaceutical Ingredients Manufacturing Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Region (2024-2024) & (Tons)
Table 39. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Region (2024-2024)
Table 40. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Region (2024-2024) & (US$ Million)
Table 41. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Region (2024-2024)
Table 42. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2024)
Table 43. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Region (2024-2034) & (Tons)
Table 44. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Region (2024-2034)
Table 47. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2034)
Table 48. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2024-2024) & (Tons)
Table 50. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Application (2024-2024)
Table 51. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2024-2024) & (US$ Million)
Table 52. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Application (2024-2024)
Table 53. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Price by Application (2024-2024) & (US$/Ton)
Table 54. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2024-2034) & (Tons)
Table 55. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Application (2024-2034)
Table 58. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Price by Application (2024-2034) & (US$/Ton)
Table 59. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2024-2024) (Tons)
Table 60. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2024-2024) (Tons)
Table 62. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2024-2024) (Tons)
Table 64. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2024-2024) (Tons)
Table 66. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2024-2024) (Tons)
Table 68. Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2024-2024) & (US$ Million)
Table 69. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2024) & (Tons)
Table 70. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Country (2024-2024)
Table 71. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2024) & (US$ Million)
Table 72. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Country (2024-2024)
Table 73. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2034) & (Tons)
Table 74. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2024) & (Tons)
Table 78. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Country (2024-2024)
Table 81. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2034) & (Tons)
Table 82. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Region (2024-2024) & (Tons)
Table 86. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Region (2024-2034) & (Tons)
Table 90. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2024) & (Tons)
Table 94. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2034) & (Tons)
Table 98. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2024) & (Tons)
Table 102. Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2034) & (Tons)
Table 106. Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Country (2024-2034)
Table 109. Alivira Animal Health Ltd. Company Information
Table 110. Alivira Animal Health Ltd. Introduction and Business Overview
Table 111. Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 112. Alivira Animal Health Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product
Table 113. Alivira Animal Health Ltd. Recent Development
Table 114. Excel Industries Ltd. Company Information
Table 115. Excel Industries Ltd. Introduction and Business Overview
Table 116. Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 117. Excel Industries Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product
Table 118. Excel Industries Ltd. Recent Development
Table 119. Ofichem Group Company Information
Table 120. Ofichem Group Introduction and Business Overview
Table 121. Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 122. Ofichem Group Veterinary Active Pharmaceutical Ingredients Manufacturing Product
Table 123. Ofichem Group Recent Development
Table 124. Chempro Pharma Private Ltd. Company Information
Table 125. Chempro Pharma Private Ltd. Introduction and Business Overview
Table 126. Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 127. Chempro Pharma Private Ltd. Veterinary Active Pharmaceutical Ingredients Manufacturing Product
Table 128. Chempro Pharma Private Ltd. Recent Development
Table 129. Menadiona Company Information
Table 130. Menadiona Introduction and Business Overview
Table 131. Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 132. Menadiona Veterinary Active Pharmaceutical Ingredients Manufacturing Product
Table 133. Menadiona Recent Development
Table 134. SUANFARMA Company Information
Table 135. SUANFARMA Introduction and Business Overview
Table 136. SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 137. SUANFARMA Veterinary Active Pharmaceutical Ingredients Manufacturing Product
Table 138. SUANFARMA Recent Development
Table 139. Vetpharma (Insud Pharma, S.L.U) Company Information
Table 140. Vetpharma (Insud Pharma, S.L.U) Introduction and Business Overview
Table 141. Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 142. Vetpharma (Insud Pharma, S.L.U) Veterinary Active Pharmaceutical Ingredients Manufacturing Product
Table 143. Vetpharma (Insud Pharma, S.L.U) Recent Development
Table 144. Siflon Drugs Company Information
Table 145. Siflon Drugs Introduction and Business Overview
Table 146. Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 147. Siflon Drugs Veterinary Active Pharmaceutical Ingredients Manufacturing Product
Table 148. Siflon Drugs Recent Development
Table 149. Qilu Pharma Company Information
Table 150. Qilu Pharma Introduction and Business Overview
Table 151. Qilu Pharma Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 152. Qilu Pharma Veterinary Active Pharmaceutical Ingredients Manufacturing Product
Table 153. Qilu Pharma Recent Development
Table 154. FIS - Fabbrica Italiana Sintetici S.p.A. Company Information
Table 155. FIS - Fabbrica Italiana Sintetici S.p.A. Introduction and Business Overview
Table 156. FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2024-2024)
Table 157. FIS - Fabbrica Italiana Sintetici S.p.A. Veterinary Active Pharmaceutical Ingredients Manufacturing Product
Table 158. FIS - Fabbrica Italiana Sintetici S.p.A. Recent Development
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trends
Table 162. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Drivers
Table 163. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Challenges
Table 164. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Restraints
Table 165. Veterinary Active Pharmaceutical Ingredients Manufacturing Distributors List
Table 166. Veterinary Active Pharmaceutical Ingredients Manufacturing Downstream Customers
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Veterinary Active Pharmaceutical Ingredients Manufacturing Product Picture
Figure 2. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Status and Outlook (2024-2034) & (Tons)
Figure 5. Product Picture of Antiparasitic
Figure 6. Global Antiparasitic Sales YoY Growth (2024-2034) & (Tons)
Figure 7. Product Picture of Anti-infectives
Figure 8. Global Anti-infectives Sales YoY Growth (2024-2034) & (Tons)
Figure 9. Product Picture of NSAIDs
Figure 10. Global NSAIDs Sales YoY Growth (2024-2034) & (Tons)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2024-2034) & (Tons)
Figure 13. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share by Type in 2022 & 2034
Figure 15. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Type in 2022
Figure 16. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Type in 2022
Figure 17. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Type in 2022
Figure 18. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Type in 2022
Figure 21. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Veterinary Active Pharmaceutical Ingredients Manufacturing Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Veterinary Active Pharmaceutical Ingredients Manufacturing Revenue in 2022
Figure 27. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Companion Animals
Figure 29. Global Companion Animals Sales YoY Growth (2024-2034) & (Tons)
Figure 30. Product Picture of Production/Food Animals
Figure 31. Global Production/Food Animals Sales YoY Growth (2024-2034) & (Tons)
Figure 32. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales by Application (2024-2034) & (US$ Million)
Figure 33. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share by Application in 2022 & 2034
Figure 34. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Application in 2022
Figure 35. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Application in 2022
Figure 36. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Application in 2022
Figure 37. Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Application in 2022
Figure 40. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Veterinary Active Pharmaceutical Ingredients Manufacturing Manufacturing Cost Structure
Figure 45. Veterinary Active Pharmaceutical Ingredients Manufacturing Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries